Takeda Pharmaceutical (TAK) Interest & Investment Income (2017 - 2026)
Takeda Pharmaceutical's Interest & Investment Income was $154.39 million in the quarter ended Jun 30, 2026, down 69.7% from $509.75 million a year earlier and down 67.2% from the prior quarter.
Takeda Pharmaceutical (TAK) Interest & Investment Income (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Takeda Pharmaceutical's Interest & Investment Income was $2.14 billion through Jun 30, 2026, up 50.4% year-over-year; for the year ended Mar 31, 2026, it came in at $1.4 billion, up 359.1% from the prior year.
- Interest & Investment Income shows a five-year compound annual growth rate of 7.1% (years ended Mar 2021 to Mar 2026).
- In earlier years, Interest & Investment Income was $305.59 million in the year ended Mar 31, 2025 (-15.4%), $361.22 million in the year ended Mar 31, 2024 (-22.4%), $465.7 million in the year ended Mar 31, 2023 (+120.6%) and $211.1 million in the year ended Mar 31, 2022 (-78.8%).
- Quarterly Interest & Investment Income has moved between $94.71 million (the quarter ended Dec 31, 2023) and $1.4 billion (the quarter ended Sep 30, 2025) over five years.
- Compared with a year earlier, Interest & Investment Income has declined for three straight quarters, with growth averaging 72.7% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was the quarter ended Sep 30, 2025 (growth of 352.4%); the worst was the quarter ended Jun 30, 2026 (a decline of 69.7%).
- Per Business Quant data, TAK's Interest & Investment Income in the three quarters before the quarter ended Jun 30, 2026 was $470.59 million (quarter ended Mar 31, 2026), $121.51 million (quarter ended Dec 31, 2025) and $1.4 billion (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 154.39 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.39 Mn |
| Mar 31, 2026 | 470.59 Mn |
| Dec 31, 2025 | 121.51 Mn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 509.75 Mn |
| Mar 31, 2025 | 483.73 Mn |
| Dec 31, 2024 | 123.00 Mn |
| Sep 30, 2024 | 309.06 Mn |
| Jun 30, 2024 | 197.07 Mn |
| Mar 31, 2024 | 207.16 Mn |
| Dec 31, 2023 | 94.71 Mn |
| Sep 30, 2023 | 381.54 Mn |
| Jun 30, 2023 | 193.04 Mn |
| Mar 31, 2023 | 460.40 Mn |
| Dec 31, 2022 | 295.02 Mn |
| Sep 30, 2022 | 107.03 Mn |
| Jun 30, 2022 | 471.10 Mn |
| Jun 30, 2021 | 418.85 Mn |
| Mar 31, 2021 | 448.67 Mn |
| Dec 31, 2020 | 271.81 Mn |
Takeda Pharmaceutical Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();